Antenatal Indomethacin Treatment for Congenital Myotonic Dystrophy
Myotonic dystrophy is an autosomal-dominant disorder. Its congenital type is the most severe form, with respiratory failure that can be a life-threatening event after birth. There are no antenatal treatments that can improve neonatal outcomes of myotonic dystrophy. We treated a fetus with congenital...
Saved in:
Main Authors: | Kyohei Yamaguchi, Hiroaki Tanaka, Fumi H. Furuhashi, Kayo Tanaka, Eiji Kondo, Tomoaki Ikeda |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Obstetrics and Gynecology |
Online Access: | http://dx.doi.org/10.1155/2019/4290145 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myotonic Steiner dystrophy in a family. Case Presentation
by: María Octavina Rodríguez Roque, et al.
Published: (2020-02-01) -
Anesthetic Considerations in a Patient with Myotonic Dystrophy for Hip Labral Repair
by: Ramon Go, et al.
Published: (2017-01-01) -
Surgical Orthodontic Treatment of a Patient Affected by Type 1 Myotonic Dystrophy (Steinert Syndrome)
by: Laura Cacucci, et al.
Published: (2017-01-01) -
Sensitivity to Rocuronium-Induced Neuromuscular Block and Reversibility with Sugammadex in a Patient with Myotonic Dystrophy
by: Akihiro Kashiwai, et al.
Published: (2012-01-01) -
FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models
by: Timothy Weeden, et al.
Published: (2025-01-01)